Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
-
Published:2023-06-14
Issue:11
Volume:44
Page:4001-4011
-
ISSN:1590-1874
-
Container-title:Neurological Sciences
-
language:en
-
Short-container-title:Neurol Sci
Author:
Mosconi PaolaORCID, Guerra TommasoORCID, Paletta PasqualeORCID, D’Ettorre AntonioORCID, Ponzio MichelaORCID, Battaglia Mario AlbertoORCID, Amato Maria Pia, Bergamaschi RobertoORCID, Capobianco MarcoORCID, Comi Giancarlo, Gasperini ClaudioORCID, Patti Francesco, Pugliatti Maura, Ulivelli MonicaORCID, Trojano MariaORCID, Lepore VitoORCID, Aguglia U., Amato MP., Ancona AL., Ardito B., Avolio C., Balgera R., Banfi P., Barcella V., Barone P., Bellantonio P., Berardinelli A., Bergamaschi R., Bertora P., Bianchi M., Bramanti P., Brescia Morra V., Brichetto G., Brioschi AM., Buccafusca M., Bucello S., Busillo V., Calchetti B., Cantello R., Capobianco M., Capone F., Capone L., Cargnelutti D., Carozzi M., Cartechini E., Cavaletti G., Cavalla P., Celani MG., Clerici R., Clerico M., Cocco E., Torri Clerici V., Coniglio MG., Conte A., Corea F., Cottone S., Crociani P., D’Andrea F., Danni MC., De Luca G., de Pascalis D., De Riz M., De Robertis F., De Rosa G., De Stefano N., Della Corte M., Di Sapio A., Docimo R., Falcini M., Falcone N., Fermi S., Ferraro E., Ferrò MT., Fortunato M., Foschi M., Gajofatto A., Gallo A., Gallo P., Gatto M., Gazzola P., Giordano A., Granella F., Grasso MG., Grimaldi LME., Iaffaldano P., Immovilli P., Imperiale D., Inglese M., Iodice R., Leva S., Leuzzi V., Lugaresi A., Lus G., Maimone D., Mancinelli L., Maniscalco GT., Marfia GA., Margari L., Marinelli F., Marini B., Marson A., Mascoli N., Massacesi L., Melani F., Merello M., Fioretti C., Mirabella M., Montepietra S., Nasuelli D., Nicolao P., Pasquali L., Passantino F., Patti F., Pecori C., Peresson M., Pesci I., Piantadosi C., Piras ML., Pizzorno M., Plewnia K., Pozzilli C., Protti A., Quatrale R., Realmuto S., Ribizzi G., Rinalduzzi S., Rini A., Romano S., Filippi M., Ronzoni M., Rossi P., Rovaris M., Salemi G., Santangelo G., Santangelo M., Leone A., Sarchielli P., Sinisi L., Ferraro D., Solaro C., Spitaleri D., Strumia S., Tassinari T., Santuccio G., Tortorella C., Totaro R., Tozzo A., Trivelli G., Turano G., Ulivelli M., Valentino P., Venturi S., Vianello M., Zaffaroni M., Zarbo R.,
Abstract
Abstract
Introduction
Over the years, disease registers have been increasingly considered a source of reliable and valuable population studies. However, the validity and reliability of data from registers may be limited by missing data, selection bias or data quality not adequately evaluated or checked.
This study reports the analysis of the consistency and completeness of the data in the Italian Multiple Sclerosis and Related Disorders Register.
Methods
The Register collects, through a standardized Web-based Application, unique patients.
Data are exported bimonthly and evaluated to assess the updating and completeness, and to check the quality and consistency. Eight clinical indicators are evaluated.
Results
The Register counts 77,628 patients registered by 126 centres. The number of centres has increased over time, as their capacity to collect patients.
The percentages of updated patients (with at least one visit in the last 24 months) have increased from 33% (enrolment period 2000–2015) to 60% (enrolment period 2016–2022). In the cohort of patients registered after 2016, there were ≥ 75% updated patients in 30% of the small centres (33), in 9% of the medium centres (11), and in all the large centres (2).
Clinical indicators show significant improvement for the active patients, expanded disability status scale every 6 months or once every 12 months, visits every 6 months, first visit within 1 year and MRI every 12 months.
Conclusions
Data from disease registers provide guidance for evidence-based health policies and research, so methods and strategies ensuring their quality and reliability are crucial and have several potential applications.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference44 articles.
1. Hoeijmakers F, Beck N, Wouters MWJM, Prins HA, Steup WH (2018) National quality registries: how to improve the quality of data. J Thorac Dis 10(Suppl 29):S3490–S3499. https://doi.org/10.21037/jtd.2018.04.146 2. Pop B, Fetica B, Blaga ML et al (2019) The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1):7–14. https://doi.org/10.15386/cjmed-1015 3. EMA. Guideline on registry-based studies. European Medicines Agency. Published October 15, 2021. Accessed July 12, 2022. https://www.ema.europa.eu/en/guideline-registry-based-studies-0 4. Harrison DM (2014) In the clinic. Multiple sclerosis. Ann Intern Med. 160(7):ITC4–2-ITC4–18; quiz ITC4–16. https://doi.org/10.7326/0003-4819-160-7-201404010-01004 5. Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis. Neurology 83(3):278–286. https://doi.org/10.1212/WNL.0000000000000560
|
|